Valerio Therapeutics Appoints Professor Eric Vivier as Board Observer

On December 15, 2025, Valerio Therapeutics announced the appointment of Professor Eric Vivier as an Observer to its Board of Directors. His nomination as a Director will be considered at the next shareholders' meeting. Professor Vivier is affiliated with Aix Marseille University and AP-HM, and holds a professorship at École Polytechnique. He is recognized for his contributions to immunology and has been awarded by the European Research Council.

Professor Vivier is a member of the French National Academy of Medicine and is listed among the world's highly cited researchers. His input is anticipated to enhance Valerio's oncology strategy and aid in developing innovative treatments for solid tumors.

Julien Miara, CEO of Valerio Therapeutics, highlighted the potential of leveraging Professor Vivier's extensive experience in immunology and oncology.